AVIR Operating Cash Flow (Statement)
Atea Pharmaceuticals Inc · Operating Cash Flow (Statement)
AVIR Operating Cash Flow (Statement)
Latest reported-$152.07Mperiod ending
AVIR TTM Cash from Operations (-$12.81M → -$152.07M)
TTM operating cash flow (statement)
High-resolution chart · PNG
AVIR operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -152,073,000 | |
| -147,859,000 | |
| -132,031,000 | |
| -134,205,000 | |
| -116,865,000 | |
| -126,197,000 | |
| -135,499,000 | |
| -126,936,000 | |
| -121,492,000 | |
| -95,410,000 | |
| -85,395,000 | |
| -85,106,000 | |
| -88,757,000 | |
| -91,823,000 | |
| -120,982,000 | |
| -174,860,000 | |
| -131,015,000 | |
| -129,177,000 | |
| -87,005,000 | |
| 306,939,000 | |
| 274,855,000 | |
| 284,405,000 | |
| 296,734,000 | |
| -25,715,000 | |
| -19,913,000 | |
| -14,007,000 | |
| -12,814,000 |